Immix Biopharma, Inc.IMMXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P41
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -15.46% |
| Q2 2025 | -210.20% |
| Q1 2025 | 11.62% |
| Q4 2024 | 53.96% |
| Q3 2024 | 19.53% |
| Q2 2024 | -29.65% |
| Q1 2024 | -53.45% |
| Q4 2023 | 13.92% |
| Q3 2023 | 11.09% |
| Q2 2023 | -68.04% |
| Q1 2023 | 46.41% |
| Q4 2022 | -166.94% |
| Q3 2022 | -167.33% |
| Q2 2022 | 63.40% |
| Q1 2022 | -34.17% |
| Q4 2021 | -2094.86% |
| Q3 2021 | 67.88% |
| Q2 2021 | 40.88% |
| Q1 2021 | -268.15% |
| Q4 2020 | 321.60% |
| Q3 2020 | 70.84% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |